Search results
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 5 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 5 days agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 5 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 5 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 5 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain ...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 7 days agoCases are “stable or uncertain” in 18 others and are likely declining in one—Oklahoma. Do Vaccines...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 5 days agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration ...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 6 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 2 days agoWedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...